Effects of UFT (mixed compound of tegafur and uracil) on cell kinetics and inhibition of thymidylate synthase in L1210 ascites tumor

Cancer Invest. 1995;13(5):470-4. doi: 10.3109/07357909509024909.

Abstract

Previous work in our laboratory showed that UFT (mixed compound of tegafur and uracil, molar ratio 1:4, respectively) caused the prolonged reduction of dTTP in L1210 leukemia cells in comparison with 5-fluorouracil (5-FU). The purpose of this study was to assess the effect of UFT on cell cycle distribution and thymidylate synthase activity of a leukemia cell line as compared with 5-FU. UFT and 5-FU were orally given to BDF1 mice bearing L1210 ascites tumor on day 3 after the tumor inoculation. Cell cycle distribution patterns at 24 hr after the drug administration showed a higher percentage of S phase in tumor cells treated with UFT than in those treated with 5-FU. Until 6 hr after the oral administration of the drugs, UFT inhibited the incorporation of [3H] deoxyuridine into DNA more long than 5-FU did. These results indicated that UFT has longer and stronger inhibitory effects on DNA replication than 5-FU in vivo under the employed experimental conditions (i.e., low and single doses of these fluorinated pyrimidines).

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Deoxyuridine / metabolism
  • Drug Combinations
  • Leukemia L1210 / enzymology
  • Leukemia L1210 / pathology
  • Male
  • Mice
  • Tegafur / pharmacology*
  • Thymidylate Synthase / antagonists & inhibitors*
  • Uracil / pharmacology*

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • Tegafur
  • Uracil
  • Thymidylate Synthase
  • Deoxyuridine